Deltec Asset Management LLC Invests $1.22 Million in SPDR S&P Biotech ETF $XBI

Deltec Asset Management LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 10,000 shares of the exchange traded fund’s stock, valued at approximately $1,219,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in XBI. Davis Capital Management bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $35,000. Barnes Dennig Private Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 4th quarter worth about $48,000. Premier Financial Group bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $50,000. MMA Asset Management LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $59,000. Finally, Pier 88 Investment Partners LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $60,000.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA:XBI opened at $133.28 on Monday. The company has a 50-day moving average of $127.49 and a 200-day moving average of $122.14. The company has a market capitalization of $8.76 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88. SPDR S&P Biotech ETF has a 52 week low of $75.68 and a 52 week high of $139.19.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.